NCT03327220View on ClinicalTrials.gov

Treatment With Iovera° for Total Knee Arthroplasty (TKA) Post-Operative Pain

NACompletedINTERVENTIONAL
Enrollment

124

Participants

Timeline

Start Date

November 6, 2017

Primary Completion Date

March 27, 2019

Study Completion Date

March 27, 2019

Conditions
Total Knee Arthroplasty
Interventions
DEVICE

iovera°

The iovera° device applies cold to a target nerve to cause a temporary peripheral nerve block based on a process called Wallerian degeneration (2nd degree axonotmesis) without disrupting connective nerve tissue.

Trial Locations (1)

38138

Campbell Clinic, Germantown

Sponsors
All Listed Sponsors
lead

Pacira Pharmaceuticals, Inc

INDUSTRY